Loading clinical trials...
Loading clinical trials...
This observational study aims to evaluate the efficacy and safety of intensity-modulated radiotherapy (IMRT) alone in patients with stage IB nasopharyngeal carcinoma (NPC) without high-risk features. ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Qiaojuan Guo
NCT07625423 · Head & Neck Cancer, Nasopharyngeal Cancinoma (NPC)
NCT04067830 · Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8, and more
NCT06802835 · Nasopharyngeal Cancinoma (NPC), Recurrent Nasopharynx Carcinoma, and more
NCT05910827 · Advanced or Metastatic Squamous Non-Small Cell Lung Cancer, Advanced Head and Neck Squamous Cell Carcinoma, and more
NCT06673095 · Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma AJCC v8
Fujian Cancer Hospital
Fuzhou, Fujian
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions